Encephalomyocarditis (EMC) virus RNA-dependent RNA polymerase was expressed in Escherichia coli as a fusion protein with glutathione S-transferase (GST), which allowed easy purification of the fusion protein by affinity chromatography on immobilized glutathione. Inclusion of a thrombin cleavage site between the GST carrier and the viral enzyme facilitated the release of purified mature EMC virus RNA polymerase from the GST carrier by proteolysis with thrombin. The purified recombinant enzyme has a molecular mass of about 52 kDa and is recognized by polyclonal immune serum raised against a peptide sequence corresponding to the C-terminal region of the protein. The recombinant enzyme comigrates with immunoprecipitated EMC virus RNA polymerase from infected mouse L929 cell extracts when run in parallel lanes on a sodium dodecyl sulfate-polyacrylamide gel. The enzyme exhibits rifampin-resistant, poly(A)-dependent poly(U) polymerase activity and RNA polymerase activity, which are both oligo(U) dependent. Template-size products are synthesized in in vitro reactions with EMC virus genomic RNA or globin mRNA. The availability of recombinant EMC virus RNA polymerase in a purified form will allow biochemical analysis of its role in the replication of the virus as well as structure-function studies of this unique class of enzyme.
Encephalomyocarditis (EMC) virus, a cardiovirus in the Picornaviridae family, consists of a single plus-stranded RNA genome of about 7.8 kb in size (29) . The picornavirus RNA is polyadenylated at its 3' end (49) and has a virusencoded protein, VPg, covalently attached to its 5' end (1, 21, 48) . During infection, the viral RNA is translated into a polyprotein that is subsequently cleaved by mainly virusencoded protease 3C to give rise to mature structural and nonstructural proteins (19, 26, 28, (30) (31) (32) . One of the viral nonstructural proteins, the RNA-dependent RNA polymerase (3DPol), replicates the single-stranded RNA genome, giving rise to both plus-and minus-strand RNAs (5) . Currently, there is very little detailed knowledge about the biochemistry of replication of EMC virus. On the other hand, the replication of poliovirus, an enterovirus in the picornavirus family, has been studied extensively. In vitro studies of poliovirus RNA replication have shed some light on the replication process, yet fundamental questions regarding the mechanism of initiation and the specificity of template selection are yet to be answered.
Studies with crude replication complexes isolated from infected HeLa cells, in which mainly plus-strand RNA is synthesized, provided evidence that VPg protein or one of its precursors may serve as a primer for the initiation of RNA synthesis by 3DPo1 (39) (40) (41) (42) 44) . Based on these observations, a model was proposed in which both plus-and minus-strand RNA synthesis is primed by VPg or its precursors (39) . Attempts to reconstruct the replication reaction in vitro by using purified components led to the discovery that highly purified preparations of poliovirus 3DPo1 are incapable of initiating RNA synthesis in vitro with poliovirus plusstrand RNA as the template (7, 14, 47) . Initiation of RNA synthesis required the addition of a primer in the form of oligo(U) or host factors isolated from uninfected cells (4, 6, 9, 11, 24, 50) . Mostly minus-strand RNA was synthesized in * Corresponding author. these in vitro reactions. The nature of the host factor and its role in the replication of the virus in vivo are not well understood. It has been suggested to be a protein kinase or a terminal uridylyl transferase capable of adding UMP residues to the poly(A) tail of the viral genome (2, 3, 24) . The resultant oligo(U)-poly(A) would form a hairpin structure that may serve as a primer for RNA synthesis. However, in vitro replication assays with different preparations of 3DPo' and host factor isolated from cells have yielded different products and given rise to different models for the replication of poliovirus (6, 9, 17, 18, 22, 50) .
To overcome these problems, researchers have attempted to reconstruct authentic virus replication complexes by using recombinant viral proteins expressed in nonmammalian hosts such as Escherichia coli. The expression of enzymatically active poliovirus 3DPo1 in E. coli has been reported (25, 35) . The recombinant enzyme was found to possess properties similar to the enzyme obtained from virus-infected cells. However, more recently, mature poliovirus 3DPo1 has again been expressed in E. coli and surprisingly found to synthesize dimer-sized products in the absence of a primer or host factor (33) . Because the recombinant poliovirus enzyme from different laboratories has yielded different results, we have decided to use a virus in another genus of the picornavirus family (EMC virus) to determine which of the current models of replication proposed for poliovirus hold true for other picornaviruses. As a first step, we required a purified preparation of EMC virus 3DPo'. Initial attempts to isolate the RNA polymerase of EMC virus from infected cells resulted in partially purified preparations of the enzyme which exhibited poly(C)-dependent RNA polymerase activity (34, 45) . Further characterization of the enzyme could not be carried out because of the instability of the enzyme. To overcome this problem, we have produced the mature EMC virus 3DPo1 in E. coli with an expression system which permits extremely rapid purification of a highly active enzyme under nondenaturing conditions.
SANKAR AND PORTER

MATERIALS AND METHODS
Construction of plasmid pT12. The plasmid pEM3, containing a cDNA copy of 7,200 nucleotides from the 3' end of the EMC virus genome, was obtained from Ann C. Palmenberg (29) . The expression vector, pGEX-1, was purchased from AMRAD Corporation, Victoria, Australia. The vector contains the glutathione S-transferase (GST) gene from Schistosoma japonicum under the control of the tac promoter (37, 38) . Downstream blot analysis. Polyclonal antisera were raised against a synthetic peptide corresponding to a predicted hydrophilic surface region of 3DPo1 near the C-terminus. The peptide sequence chosen was Cys-Gly-Gly-Gly-Leu-Lys-Arg-LysPhe-Lys-Lys-Glu-Gly-Pro-Leu-Tyr. A nonnatural cysteine and three glycine spacers were added to the N-terminus of the peptide to enable linkage to the carrier protein, keyhole limpet hemocyanin (Sigma Chemical Co.). Linkage was carried out with the bifunctional reagent m-maleimidobenzoyl-N-hydroxy succinimide ester (27 (16) . After transfer, the blots were soaked in 5% nonfat skimmed milk in phosphatebuffered saline for 1 h to saturate the additional binding sites. The blots were then treated sequentially with biotinylated goat anti-rabbit immunoglobulin antisera followed by streptavidin-horseradish peroxidase conjugate and reacted with 4-chloro-1-naphthol as the chromogenic substrate.
Preparation of viral genomic RNA and oligo(U) primer. EMC virus RNA was prepared by the procedure described by Sankar et al. (36) . Briefly, infected mouse L929 cells were treated to two freeze-thaw cycles, and the virions released into the supernatant were precipitated with an equal volume of 14% (wt/vol) polyethylene glycol-4.6% (wt/vol) NaCl and centrifuged. The virion pellet, resuspended in 5 ml of buffer (50 (12) except that rifampin at a concentration of 20 ,ug/ml was used instead of dactinomycin.
The reactions were carried out at 30°C for 60 min in 50 pul containing 5 ,ul (-600 ng) of the purified enzyme, 50 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid, pH 8.0), 10 To obtain large quantities of recombinant EMC virus 3DPo1 in a form that can be easily purified, we used the expression vector pGEX-1, which directs the synthesis of foreign polypeptides in E. coli as fusions with a 26-kDa GST encoded by the parasitic helminth Schistosoma japonicum (38) . This expression system, based on the E. coli tac promoter, provides a convenient means for the expression of fusion proteins in E. coli and their subsequent purification by affinity chromatography on immobilized glutathione under nondenaturing conditions. The cloning strategy used to generate the expression vector pT12 expressing EMC virus 3DP01 as a fusion protein is shown in Fig. 1 4 h, after which total-cell extracts were prepared and analyzed in a 0.1% SDS-10% polyacrylamide gel, which was stained with Coomassie brilliant blue. Lane 1, polypeptide profile obtained from pGEX-1. The dot indicates the 27.5-kDa GST protein specified by pGEX-1. Lane 2, polypeptides synthesized by E. coli harboring pT12. The dot denotes the fusion protein of GST and EMC virus 3DP01. Lane EMC virus 3DPo'. To show that this band was indeed the fusion protein, extracts prepared from sonicated IPTGinduced cells harboring pT12 were passed through a glutathione-Sepharose column which had been equilibrated with buffer 1. The bound protein was eluted with buffer 1 containing 5 mM reduced glutathione and shown to be approximately 78 kDa in size (Fig. 2, lane 3) .
Preliminary experiments with purified fusion protein indicated that the 3DPo1 could be released from the carrier protein by thrombin cleavage (data not shown), but the released recombinant protein had to be separated from GST by rechromatography on glutathione-Sepharose. Previous data (34, 45) indicated that partially purified EMC virus 3DPo1 isolated from infected cells is labile. Therefore, to further reduce the number of steps required for purification, we developed an essentially one-step purification of EMC virus 3DPo1 by in situ proteolysis of the fusion protein immobilized on the glutathione-Sepharose column (15) . In addition, all steps, including thrombin cleavage, were performed at 4°C. In the modified procedure, the fusion protein was not eluted with glutathione. Instead, the gel slurry containing bound fusion protein was incubated with thrombin for several hours at 4°C to allow proteolytic digestion of the fusion protein. predicted from the cDNA sequence (29) .
Generation of antibodies to EMC virus 3DP'". To aid in the detection of EMC the labeled proteins bound to antibody were collected by centrifugation and analyzed by SDS-PAGE and autoradiography. Figure 3 (lane 1) shows the protein profile obtained from EMC virus-infected mouse L929 cell extracts. The bands correspond to [35S]methionine-labeled virus-specified proteins. The immune sera detected the EMC virus 3DPo1 as well as its precursors 3CD and P3 (Fig. 3, lane 3) , whereas the preimmune sera did not immunoprecipitate any labeled material from the infected cell extract (Fig. 3, lane 2) .
The immune serum generated against EMC virus 3DPol was subsequently used in an immunoblot analysis to detect the expression of EMC virus 3DPo' in extracts prepared from induced E. coli containing the vector alone or the recombinant (pT12). The immune serum did not react with control extracts prepared from E. coli harboring the vector alone (Fig. 4B, lane 1) . However, a protein band of about 78 kDa, corresponding to the size of the fusion protein of GST and EMC virus 3DPo1, was detected by the immune serum in both the crude soluble extracts (Fig. 4B, lane 2) and to a greater extent in the material eluted from the glutathione-Sepharose column (Fig. 4B, lane 3) . Finally, the 52-kDa 3DPo1 released by thrombin cleavage of the fusion protein also reacted with the immune serum (Fig. 4B, lane 4) . The purified recombinant EMC virus 3DPoI migrated with the same mobility as immunoprecipitated [35S]methionine-labeled EMC virus 3DPo isolated from EMC virus-infected mouse L929 cells when run in parallel lanes on an SDS-polyacrylamide gel (data not shown).
Characterization of enzymatic activity of recombinant EMC virus 3DPo1. As a first step towards establishing an assay system for the 3DPo1, we used the poly(A)-dependent oligo(U)-primed poly(U) polymerase assay as described by Flanegan and Baltimore (12, 13) . Very low concentrations of the purified recombinant 3DPo1 exhibited significant poly(U) polymerase activity that was resistant to rifampin (Table 1) . Rifampin, an antibiotic which is known to block the reinitiation of RNA chains by the E. coli DNA-dependent RNA polymerase (8) , was included in the assays to determine the contribution, if any, of the E. coli DNA-dependent RNA polymerase to the poly(U) polymerase activity detected in our assays. As indicated in Table 1 , rifampin at 20 ,ug/ml had virtually no effect on the poly(U) polymerase activity of recombinant EMC virus 3DP01. In contrast, purified E. coli DNA-dependent RNA polymerase exhibited significant poly(U) polymerase activity, which was almost completely inhibited in the presence of rifampin at 20 ,ug/ml ( Table 1) .
RECOMBINANT EMC VIRUS
The poly(U) polymerase activity exhibited by 3DPo1 was next characterized with respect to template and primer requirements for activity. The poly(U) polymerase activity was completely dependent on the addition of both poly(A) and oligo(U) ( Table 1) . Oligo(dT) was as efficient as oligo(U) as a primer in the poly(U) polymerase assay when added at the same concentration (data not shown). The enzyme activity was inhibited by KCI and EDTA, as for poliovirus 3DP01 (7, 10) .
Further biochemical characterization of the recombinant 3DP01 was carried out to determine the kinetics of poly(U) polymerase activity as well as the temperature optimum for the reaction. The poly(U) polymerase activity was linear for 60 min (Fig. SA) , and the temperature optimum for the reaction was 30°C (Fig. SB) . The amount of product synthesized in a 60-min reaction by the purified recombinant enzyme was found to be a linear function of enzyme concentration up to 1.2 ,ug of protein (Fig. SC) . At higher concentrations, a drop in activity was noted. This can be explained by the presence of glycerol in the enzyme storage buffer, which at high concentration could inhibit the poly(U) polymerase activity. Finally, the purified recombinant EMC virus 3DPo1 was calculated to have a specific activity of 27 pmol of UMP incorporated per ,ug of protein in a 60-min reaction at 30°C. This value is 2 orders of magnitude lower than the value reported by Plotch and coworkers (33) for the recombinant poliovirus 3DP0' but is similar to the value reported by Morrow et al. (25) for their preparation of recombinant poliovirus 3DPo'.
To determine whether the recombinant enzyme exhibits any RNA polymerase activity, plus-strand EMC virus RNA was incubated with the purified enzyme in the presence of oligo(U) and all four ribonucleoside triphosphates. RNA molecules over a wide range of sizes were synthesized by the recombinant EMC virus 3DPo1, the most prominent being about 7.8 kb in length, which corresponds to full-length EMC virus RNA (Fig. 6, lane 1) . To further confirm that template-size products can be synthesized in an in vitro reaction, the enzyme was incubated with purified globin mRNA, and template-size copies of globin mRNA of -600 nucleotides were synthesized (Fig. 6, lane 2) . The presence of a smear of products rather than a clean single band (Fig.  6, lanes 1 and 2) is probably due to premature termination of the enzyme activity rather than nucleolytic degradation, since the assays were carried out in the presence of human placental RNase inhibitor. When the enzyme was incubated with EMC virus template RNA in the absence of an oligo(U) primer, no products were detected (data not shown). These results differ from the observations made by Plotch and coworkers (33) , who reported that their recombinant poliovirus 3DP01 exhibits oligo(U)-independent RNA polymerase activity, resulting in the synthesis of products up to twice the size of the template. fected eukaryotic cells met with difficulties owing to the low content of the enzyme, the association of the enzyme with smooth cytoplasmic membranes, requiring the use of detergents to separate the enzyme from the membrane, and the instability of partially purified preparations of the enzyme. Nevertheless, Traub et al. (45) reported poly(C)-dependent polymerase activity of partially purified preparations of authentic EMC virus 3DPo1. Our recombinant enzyme, on the other hand, shows poly(A)-dependent poly(U) polymerase activity, which was absent from their partially purified extracts of EMC virus 3DP"". However, several lines of 50 60 evidence support the conclusion that the recombinant EMC virus 3DPo1 is indeed the viral RNA polymerase holoenzyme. First, the size of the recombinant protein is 52 kDa, which correlates with the size predicted from the cDNA (29) . In addition, when run in parallel lanes on an SDS-polyacrylamide gel, the recombinant enzyme migrates with the same mobility as the immunoprecipitated [35S]methionine-labeled EMC virus 3DP"' obtained from infected mouse L929 cell extracts. Second, the protein is recognized by specific immune serum raised against a peptide sequence corresponding to the C-terminal region of EMC virus 3DPo1. Third, the amino acid sequence we derived for the N-terminal 20 amino acids of the purified protein matches exactly the sequence predicted from the cDNA (29) . Fourth, the recombinant enzyme exhibits several enzymatic properties analogous to those observed for poliovirus 3DP"' isolated from infected HeLa cells (7, 10, 12, 13, 46) , i.e., poly(U) polymerase activity that is template and primer dependent and is sensi-their enzyme may have an N-terminal methionine that imparts this additional ability to the recombinant 3DPo1. The expression of enzymatically active EMC virus 3DPo1 in E. coli provides a starting point for further experiments to understand the mechanism of replication of EMC virus. In addition, the availability of purified EMC virus RNA polymerase will also allow us to map the functional domains of this unique enzyme and determine its relatedness to the DNA-dependent RNA polymerases and reverse transcriptases. Because the GST expression system has allowed the purification of milligram quantities of EMC virus 3DP01, attempts to crystallize this enzyme and solve its structure are now in progress.
DISCUSSION
